Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target
10/20/2026
Impact: 70
Healthcare
Cantor Fitzgerald analyst Olivia Brayer Saunders has reiterated an Overweight rating on MannKind (NASDAQ: MNKD) and maintained a price target of $8 for the stock. This endorsement reflects confidence in the company's performance and future prospects.
AI summary, not financial advice
Share: